Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Parkinson’s UK

Mission awarded $5.2m to advance potential Parkinson’s treatment

Mission awarded .2m to advance potential Parkinson’s treatment
p p Read More

The progressive neurodegenerative condition affects around 153,000 people in the UK

July 8, 2024 Michael J. Fox Foundation, Mission Therapeutics, MTX325, neurodegenerative diseases, News, Parkinson's disease, Parkinson’s UK

Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease

Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease
p p Read More

The neurodegenerative condition currently affects around 153,000 people in the UK

June 28, 2024 brain simulation, GPNMB, Imperial College London, neurodegenerative diseases, News, Parkinson's disease, Parkinson’s UK

LucyTx announces additional $12.5m research funding for neurological diseases

LucyTx announces additional .5m research funding for neurological diseases
p p Read More

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally

June 11, 2024 Alzheimer's disease, Bill & Melinda Gates Foundation, Lucy Therapeutics, Michael J. Fox Foundation, neurological conditions, News, Parkinson's disease, Parkinson’s UK, Rett syndrome, Safar Partners

Researchers reveal people with Parkinson’s more likely to experience delirium in hospital

Two out of three people with the neurodegenerative condition experienced delirium in hospital

April 2, 2024 delirium, neurogenerative conditions, Newcastle University, News, Parkinson's disease, Parkinson’s UK

Parkinson’s UK grants funding of up to nearly £450,000 to four new research projects

The globally fast-growing progressive neurological condition affects around 153,000 people in the UK

March 21, 2024 King’s College London, London Metropolitan University, neurological diseases, News, Parkinson's disease, Parkinson’s UK, Robert Gordon University, University of Nottingham

Predict-PD study to identify those at high risk of PD before symptoms appear

The study aims to improve the representation of ethnic diversity within Parkinson’s research

February 19, 2024 News, Parkinson's disease, Parkinson’s UK, Queen Mary University, uMed, University College London
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy